
Liminatus Pharma, Inc. — Investor Relations & Filings
Liminatus Pharma, Inc. is a pre-clinical-stage biopharmaceutical company focused on developing novel, immune-modulating cancer therapies. The company specializes in immuno-oncology and is pioneering the development of a second-generation CD47-blockade antibody. This therapeutic approach is designed to utilize the patient's immune system to target and destroy cancer cells. Its lead clinical candidate, IBA101, is a humanized anti-CD47 antibody being advanced toward clinical trials for the treatment of various cancers.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 424B3 | 2026-06-03 | English | |
| FORM 8-K | 2026-05-27 | English | |
| FORM 8-K | 2026-05-20 | English | |
| 10-Q | 2026-05-15 | English | |
| 10-K - Liminatus Pharma, Inc. (0001971387) (Filer) | 2026-03-31 | English | |
| 8-K - LIMINATUS PHARMA, INC. (0001971387) (Filer) | 2026-03-04 | English |
Browse filings by year
4 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
11 filings
| |||||
| 47948572 | 424B3 | 2026-06-03 | English | ||
| 47845366 | FORM 8-K | 2026-05-27 | English | ||
| 46693288 | FORM 8-K | 2026-05-20 | English | ||
| 46362206 | 10-Q | 2026-05-15 | English | ||
| 33122863 | 10-K - Liminatus Pharma, Inc. (0001971387) (Filer) | 2026-03-31 | English | ||
| 32900806 | 8-K - LIMINATUS PHARMA, INC. (0001971387) (Filer) | 2026-03-04 | English | ||
| 32267708 | 8-K Filing | 2026-02-18 | English | ||
| 32267649 | 424B4 Filing | 2026-02-18 | English | ||
| 32267778 | S-1 Filing | 2026-02-11 | English | ||
| 32267630 | 8-K Filing | 2026-02-09 | English | ||
| 13651327 | FORM 8-K | 2026-01-26 | English | ||
|
2025
4 filings
| |||||
| 13651348 | FORM 8-K | 2025-11-25 | English | ||
| 13651425 | 10-Q | 2025-11-14 | English | ||
| 13651432 | 10-Q | 2025-10-04 | English | ||
| 13651428 | FORM 8-K | 2025-08-25 | English | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
CORCEPT THERAPEUTICS INC
Develops and commercializes cortisol-modulating medications…
|
CORT | US | Manufacturing |
|
Corline Biomedical AB
Develops heparin-based solutions for medical devices and re…
|
CLBIO | SE | Manufacturing |
|
CorMedix Inc.
Biopharma firm developing therapeutics for infectious and i…
|
CRMD | US | Manufacturing |
|
Corona Remedies Limited
Develops and manufactures therapeutic solutions across dive…
|
CORONA | IN | Manufacturing |
|
Corvus Pharmaceuticals, Inc.
Clinical-stage biopharma developing therapies for immune di…
|
CRVS | US | Manufacturing |
|
COSCIENS Biopharma Inc.
Develops and commercializes natural-based active ingredient…
|
CSCI | CA | Manufacturing |
|
Cosma Spolka Akcyjna
Manufactures and distributes hemp and cannabis products for…
|
COS | PL | Manufacturing |
|
COSMO Pharmaceuticals N.V.
A specialty pharmaceutical firm focused on gastroenterology…
|
COPN | NL | Manufacturing |
|
Cosmos Health Inc.
Vertically integrated healthcare group in the nutraceutical…
|
COSM | US | Manufacturing |
|
Cotinga Pharmaceuticals Inc.
Clinical-stage biopharma developing AI-driven therapeutics …
|
COT | CA | Manufacturing |
Liminatus Pharma, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/34636/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=34636 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=34636 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=34636 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 34636}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Liminatus Pharma, Inc. (id: 34636)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.